Status:
COMPLETED
Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion
Lead Sponsor:
Medical College of Wisconsin
Collaborating Sponsors:
Children's Hospital and Health System Foundation, Wisconsin
Conditions:
Postoperative Pain
Eligibility:
All Genders
9-18 years
Phase:
NA
Brief Summary
Blinded study using oral gabapentin in load pre-operative (15mg/kg) and maintenance 5mg/kg three times a day (TID) for 5 days or discharge, Patient Controlled Analgesia (PCA) morphine and placebo grou...
Detailed Description
Healthy, American Society of Anesthesia (ASA) 1-2 Idiopathic Scoliosis patients for spinal fusion. Blinded, drug only known by hospital pharmacist. Study group 1- Gabapentin 15mg/kg with premed, 5/kg...
Eligibility Criteria
Inclusion
- ASA 1-2, Idiopathic Scoliosis
Exclusion
- ASA 3 or greater
- Neuromuscular scoliosis
- On narcotics baseline
Key Trial Info
Start Date :
June 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT00726999
Start Date
June 1 2006
End Date
May 1 2009
Last Update
April 3 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.